La esteatosis hepática se asocia con infección del sitio quirúrgico

1.    Sax H., Uckay I., Balmelli C., et al. Overall burden of healthcare-associated infections among surgical patients. Results of a national study. Ann Surg 2011; 253: 365-370.
2.    Haridas M., Malangoni M.A.: Predictive factors for surgical site infection in general surgery. Surgery 2008; 144: 496-501discussion 501-3.
3.    Blumetti J., Luu M., Sarosi G., et al. Surgical site infections after colorectal surgery: do risk factors vary depending on the type of infection considered?. Surgery 2007; 142: 704-711
4.    Kurmann A., Vorburger S.A., Candinas D., et al. Operation time and body mass index are significant risk factors for surgical site infection in laparoscopic sigmoid resection: a multicenter study. Surg Endosc 2011; 25: 3531-3534.
5.    Pischon T., Boeing H., Hoffmann K., et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
6.    Speliotes E.K., Massaro J.M., Hoffmann U., et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51: 1979-1987.
7.    Calori G., Lattuada G., Ragogna F., et al Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011; 54: 145-152.
8.    Tsujinaka S., Konishi F., Kawamura Y.J., et al. Visceral obesity predicts surgical outcomes after laparoscopic colectomy for sigmoid colon cancer. Dis Colon Rectum 2008; 51: 1757-1765discussion 1765-7.
9.    Tokunaga M., Hiki N., Fukunaga T., et al. Effect of individual fat areas on early surgical outcomes after open gastrectomy for gastric cancer. Br J Surg 2009; 96: 496-500.
10.    Park B.J., Kim Y.J., Kim D.H., et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 2008; 23: 900-907.
11.    Jang S., Lee C.H., Choi K.M., et al. Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol. World J Gastroenterol 2011; 17: 3335-3341.
12.    Thomas E.L., Hamilton G., Patel N., et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005; 54: 122-127.
13.    D'Alessandro A.M., Kalayoglu M., Sollinger H.W., et al. The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant Proc 1991; 23: 1536-1537.
14.    Beldi G., Bisch-Knaden S., Banz V., et al. Impact of intraoperative behavior on surgical site infections. Am J Surg 2009; 198: 157-162.
15.    National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485.
16.    Sugisawa N., Tokunaga M., Tanizawa Y., et al. Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer 2012; 15: 206-212.
17.    Lee J., Chung D.S., Kang J.H., et al. Comparison of visceral fat and liver fat as risk factors of metabolic syndrome. J Korean Med Sci 2012; 27: 184-189.
18.    Kim L.J., Nalls M.A., Eiriksdottir G., et al. Associations of visceral and liver fat with the metabolic syndrome across the spectrum of obesity: the AGES-Reykjavik study. Obesity (Silver Spring) 2011; 19: 1265-1271.
19.    Kooby D.A., Fong Y., Suriawinata A., et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7: 1034-1044.
20.    Liu K.H., Chan Y.L., Chan J.C., et al. Mesenteric fat thickness as an independent determinant of fatty liver. Int J Obes (Lond) 2006; 30: 787-793.
21.    Salgado W., de Queiroz Cunha F., dos Santos J.S., et al. Early identification of infectious complications in bariatric surgery by the determination of peritoneal and systemic cytokines. Obes Surg 2009; 19: 867-872.
22.    Schindl M.J., Redhead D.N., Fearon K.C., et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-296.
23.    Henao-Mejia J., Elinav E., Jin C., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482: 179-185.
24.    Ashcroft G.S., Jeong M.J., Ashworth J.J., et al. Tumor necrosis factor-alpha (TNF-alpha) is a therapeutic target for impaired cutaneous wound healing. Wound Repair Regen 2012; 20: 38-49.
25.    Englesbe M.J., Lee J.S., He K., et al. Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg 2012; 256: 255-261.
26.    Lee J.S., He K., Harbaugh C.M., et al. Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg 2011; 53: 912-917.
27.    Englesbe M.J., Patel S.P., He K., et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-278.
28.    Lee J.S., Terjimanian M.N., Tishberg L.M., et al. Surgical site infection and analytic morphometric assessment of body composition in patients undergoing midline laparotomy. J Am Coll Surg 2011; 213: 236-244.
29.    House M.G., Fong Y., Arnaoutakis D.J., et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 2008; 12: 270-278.
30.    Sakai T., Maekawa T., Mikami K., et al. Visceral fat volume and surgical outcomes of colorectal resection. Int Surg 2009; 94: 370-372.
31.    Anjana M., Sandeep S., Deepa R., et al. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care 2004; 27: 2948-2953.
32.    Uchiyama K., Ueno M., Ozawa S., et al. Risk factors for postoperative infectious complications after hepatectomy. J Hepatobiliary Pancreat Sci 2010; 18: 67-73.
33.    Sadamori H., Yagi T., Shinoura S., et al. Risk factors for organ/space surgical site infection after hepatectomy for hepatocellular carcinoma in 359 recent cases. J Hepatobiliary Pancreat Sci 2013; 20: 186-196.